🇺🇸 Adjuvant chemotherapy in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Altered State Of Consciousness — 1 report (10%)
  2. Anastomotic Complication — 1 report (10%)
  3. Ataxia — 1 report (10%)
  4. Disorientation — 1 report (10%)
  5. Dysarthria — 1 report (10%)
  6. General Physical Health Deterioration — 1 report (10%)
  7. Hallucination — 1 report (10%)
  8. Inadequate Analgesia — 1 report (10%)
  9. Incoherent — 1 report (10%)
  10. Miosis — 1 report (10%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Adjuvant chemotherapy approved in United States?

Adjuvant chemotherapy does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Adjuvant chemotherapy in United States?

Institut de Cancérologie de Lorraine is the originator. The local marketing authorisation holder may differ — check the official source linked above.